We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Amneal Pharmaceuticals Inc
14 own
22 watching
Current Price
$2.14
$0
(0%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
649.58M
52-Week High
4.98
52-Week Low
1.95
Average Volume
0.79M
Dividend Yield
--
P/E Ratio
84.6746
Market Capitalization649.58M52-Week High4.9852-Week Low1.95Average Volume0.79MDividend Yield--P/E Ratio84.6746What does the Amneal Pharmaceuticals Inc do?
Amneal Pharmaceuticals, Inc., formerly known as Atlas Holdings, Inc. (the "Company"), was formed along with its wholly owned subsidiary, K2 Merger Sub Corporation, a Delaware corporation ("Merger Sub"), on October 4, 2017, for the purpose of facilitating the combination of Impax Laboratories, Inc. (now Impax Laboratories, LLC), a Delaware corporation then listed on the Nasdaq Stock Market ("Impax") and Amneal Pharmaceuticals LLC, a Delaware limited liability company ("Amneal").
Read More
How much money does Amneal Pharmaceuticals Inc make?
News & Events about Amneal Pharmaceuticals Inc.
Globe Newswire
24days ago
ORION CORPORATION PRESS RELEASE 4 JANUARY 2023 at 16.00 EET Orion and Amneal enter strategic partnership Orion receives exclusive licence to commercialise Amneals generic products in Europe, Australia and New Zealand Orion Corporation today announced it has signed a long-term license agreement with ...
Business Wire
24days ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has signed a long-term license agreement with Orion Corporation (OMXH: ORNBV & ORNAV) to commercialize a number of Amneals complex generic products. Under the partnership agreement, Orion is Amneals...
Business Wire
1month ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced that the Company has successfully launched 26 new generic products in 2022. In the fourth quarter of 2022, the Company launched 8 new generic products, including clindamycin phosphate gel 1%, ipratropium bromide nasal...
Business Wire
2 months ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the Company) today announced that the management team will attend the following investor conferences: Piper Sandler 34th Annual Healthcare Conference December 1, 2022 New York, New York 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 San...
Business Wire
2 months ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for IPX203 for the treatment of Parkinsons disease (PD). IPX203 is a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release...
Frequently Asked Questions
Frequently Asked Questions
What is Amneal Pharmaceuticals Inc share price today?
Can Indians buy Amneal Pharmaceuticals Inc shares?
How can I buy Amneal Pharmaceuticals Inc shares from India?
Can Fractional shares of Amneal Pharmaceuticals Inc be purchased?
What are the documents required to start investing in Amneal Pharmaceuticals Inc stocks?
What is today’s traded volume of Amneal Pharmaceuticals Inc?
What is today’s market capitalisation of Amneal Pharmaceuticals Inc?
What is the 52-Week High and Low Range of Amneal Pharmaceuticals Inc?
What percentage is Amneal Pharmaceuticals Inc down from its 52-Week High?
What percentage is Amneal Pharmaceuticals Inc up from its 52-Week Low?
Current Price
$2.14
$0
(0%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.